 |
Nivolumab and ipilimumab together stave off progression for up to a year Related items from OnMedica Surge in number of skin cancer admissions Guidance aims to iron out wide variations in melanoma management Sunlight still causes damage after dark Melanoma drug is first to be fast tracked under NHS early access scheme Green light for new drug for advanced skin cancer |
Monday, 1 June 2015
Immunotherapy drug combo curbs melanoma advance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment